Clinical Trial: Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study

Brief Summary: The purpose of this study is to determine if trigger point dry needling (TDN) is as effective as cortisone injection (CI) in reducing pain and improving function in patients with greater trochanteric pain syndrome (GTPS).

Detailed Summary:

This study aims to investigate the potential of TDN as an effective alternative to CI for patients with GTPS by directly comparing pain and functional outcomes of patients receiving TDN or CI for the treatment of GTPS over a 6 week period. The investigators hypothesize that patients treated with TDN will be equally improved in pain and function as those treated with CI. If TDN is demonstrated to be equally or more effective than steroid injection in this pilot study, then the investigators have the basis to launch larger studies. Ultimately, the investigators want to determine if TDN is an effective treatment alternative for GTPS for providers and patients who want to avoid the potential detrimental side-effects of steroids.

Approach: Prospective, randomized, partially-blinded design

Aim: To determine if administration of TDN is as effective as CI in reducing lateral hip pain and improving function in patients diagnosed with greater trochanteric pain syndrome. The investigators expect to demonstrate effectiveness of TDN in the treatment of GTPS to a degree that is equal to CI. Doing so would prompt further outcomes research for TDN. Supportive research and subsequent clinical acceptance of TDN as a primary treatment for this condition would offer an alternative to patients who want or need to avoid steroids.

Based on the literature, this is the first study to investigate the effectiveness of TDN in the treatment of GTPS and directly compare pain and functional outcomes of patients receiving TDN versus CI for the treatment of GTPS.

Methods. Fifty patients with GTPS will be randomized into a CI or TDN group. Treatment will be administered according to standard of care for up to 6 weeks. Numerical pain and functional ratings fo
Sponsor: Scott and White Hospital & Clinic

Current Primary Outcome:

  • Participants change in pain rating scores from baseline to 6 weeks will be accessed. [ Time Frame: Baseline and 6 weeks ]
  • Patient specific function score (PSPS) from baseline to 6 weeks will be accessed. [ Time Frame: Baseline and 6 weeks ]


Original Primary Outcome:

  • Participants change in pain rating scores from baseline to 6 weeks will be accessed. [ Time Frame: 6 weeks ]
  • Patient specific function score (PSPS) from baseline to 6 weeks will be accessed. [ Time Frame: 6 weeks ]


Current Secondary Outcome:

Original Secondary Outcome:

Information By: Scott and White Hospital & Clinic

Dates:
Date Received: December 2, 2015
Date Started: February 2013
Date Completion:
Last Updated: December 28, 2015
Last Verified: December 2015